AI made execution free. Knowing first is the whole game now.
The advantage goes to whoever is first into the right conversations, most often. Fundz stacks those odds: more of the moments that create demand than anyone else catches, as they happen, matched to who you sell to, with the decision maker to call. Now it answers in Claude too: ask for today’s leads and who to reach, then write the note in the same window. Not a feed. Not a list you rent. A system for being first.
Trusted by
Acquiring Company
Telix Pharmaceuticals Limited
Acquired Company
ITM Isotopen Technologien München AG
Melbourne
MunichBiotechnologyBiotechnologyHealth CareDescription
Telix Pharmaceuticals Limited has announced its intention to acquire ITM Isotopen Technologien München AG. This strategic takeover aims to create a global powerhouse in the radiopharmaceutical sector. The merger is expected to enhance the capabilities and offerings of both companies in cancer treatment.
Fundz sees it the moment Telix Pharmaceuticals Limited makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
M&A Insights
Based on deal dataFrequently asked
Who acquired ITM Isotopen Technologien München AG?
ITM Isotopen Technologien München AG was acquired by Telix Pharmaceuticals Limited, based in Melbourne. The deal was reported on September 21, 2026. Telix Pharmaceuticals Limited (ASX: TLX) is a leading pharmaceutical company specializing in advanced diagnostic and therapeutic radiopharmaceuticals. Telix Pharmaceuticals Limited is publicly traded (TLX) and operates in Biotechnology.
When did Telix Pharmaceuticals Limited acquire ITM Isotopen Technologien München AG?
Telix Pharmaceuticals Limited's acquisition of ITM Isotopen Technologien München AG was reported on September 21, 2026. Telix Pharmaceuticals Limited has announced its intention to acquire ITM Isotopen Technologien München AG. This strategic takeover aims to create a global powerhouse in the radiopharmaceutical sector. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does ITM Isotopen Technologien München AG do?
ITM Isotopen Technologien München AG is a leading company in the field of radioactive pharmaceuticals. Their primary focus is on the development of innovative therapies and diagnostics for targeted radiation oncology. It is privately held, operating in Biotechnology, and is based in Munich.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.
5 screens from a live account. No signup.